Presentation is loading. Please wait.

Presentation is loading. Please wait.

Adaptive Natural Killer Cell and Killer Cell Immunoglobulin–Like Receptor–Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated.

Published byStella Allen Modified over 5 years ago

Similar presentations

Presentation on theme: "Adaptive Natural Killer Cell and Killer Cell Immunoglobulin–Like Receptor–Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated."— Presentation transcript:

1 Adaptive Natural Killer Cell and Killer Cell Immunoglobulin–Like Receptor–Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation  Zachary B. Davis, Sarah A. Cooley, Frank Cichocki, Martin Felices, Rose Wangen, Xianghua Luo, Todd E. DeFor, Yenan T. Bryceson, Don J. Diamond, Claudio Brunstein, Bruce R. Blazar, John E. Wagner, Daniel J. Weisdorf, Amir Horowitz, Lisbeth A. Guethlein, Peter Parham, Michael R. Verneris, Jeffrey S. Miller  Biology of Blood and Marrow Transplantation  Volume 21, Issue 9, Pages (September 2015) DOI: /j.bbmt Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Recipient CMV Sero+/React− and React+ results in expansion of KIR2DL2/3+ and NKG2C+CD57+ NK cells after transplantation. (A) NKG2C+CD57+ cells were evaluated from Sero−/React− (black bars, n = 91), Sero+/React− (light gray bars, n = 53) and CMV React+ (white bars, n = 59), (B) NKG2C+CD57−, (C) NKG2A+, (D) KIR2DL1+, (E) KIR2DL2/3+, and (F) KIR3DL1+ expression was evaluated on CD56+CD3− NK cells after transplantation from CMV Sero−/React− (black bars, n = 116), Sero+/React− (light gray bars, n = 54), and CMV React+ (white bars, n = 57). Recipient samples were analyzed at 100 days, 6 months, and 1 year after transplantation. Bars represent the mean percentage of lymphocytes expressing each phenotype ± SEM. T test (equal variance or unequal variance t-test, based on variance test result) was used for the pairwise comparisons between groups at each time point. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3 Figure 2 Recipient CMV Sero+/React− and React+ results in expansion of KIR2DL2/3+ and NKG2C+CD57+ CD56+CD3+ T cells after HCT. (A) NKG2C+CD57+ CD56+CD3+ T cells in CMV Sero−/React− (black bars, n = 116), Sero+/React− (light gray bars, n = 53), and CMV React+ (white bars, n = 57), (B) NKG2C+CD57−, (C) NKG2A+, (D) KIR2DL1+, (E) KIR2DL2/3+ and (F) KIR3DL1+ expression was evaluated on CD56+CD3+ T cells from CMV Sero−/React− (black bars, n = 115), Sero+/React− (light gray bars, n = 54), and CMV React+ (white bars, n = 57). Analysis as in Figure 1. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

4 Figure 3 CMV Sero+/React− and React+ results in expansion of KIR2DL2/3+ and NKG2C+CD57+ CD56−CD3+ T cells after HCT. (A) NKG2C+CD57+ T cells in Sero−/React− (black bars, n = 116), Sero+/React− (light gray bars, n = 54), and CMV React+ (white bars, n = 57), (B) NKG2C+CD57−, (C) NKG2A+, (D) KIR2DL1+, (E) KIR2DL2/3+, and (F) KIR3DL1+ CD56-CD3+ T cells were evaluated from Sero−/React− (black bars, n = 116), Sero+/React− (light gray bars, n = 54) and CMV React+ (white bars, n = 57). Analysis as in Figure 1. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

5 Figure 4 Recipient CMV Sero+ is associated with increased KIR2DL2/3 and NKG2C expressing adaptive CD56+CD3− NK cells in React− recipients of sibling but not UCB grafts. CD56+CD3− NK cells from CMV Sero−/React− (▴, n = 77) or CMV Sero+/React− (□, n = 50). Shown are the percentage of cells expressing (A) KIR2DL2/3+, (B) NKG2A+, (C) NKG2C+CD57+ or (D) NKG2C+CD57−. The same subsets are shown for React− UCB HCT who were either CMV Sero−/React− (▴, n = 61) or CMV Sero+/React− (□, n = 47) (E-H). Analysis as in Figures 1 through 3. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

6 Figure 5 Recipient CMV sero+ is associated with increased KIR2DL2/3 and NKG2C expressing adaptive CD56+CD3+ T cells in React− recipients of sibling but not UCB grafts. CD56+CD3+ T cells CMV Sero−/React− (▴, n = 73) or CMV Sero+/React− (□, n = 106). Shown are the percentage of cells expressing (A) KIR2DL2/3+, (B) NKG2A+, (C) NKG2C+CD57+, or (D) NKG2C+CD57−. The same subsets are shown for React− UCB HCT who were either CMV Sero−/React− (▴, n = 59) or CMV Sero+/React− (□, n = 47) (E-H). Analysis as in Figures 1 through 3 *P < .05, **P < .01, ***P < .001. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

7 Figure 6 Cumulative incidence of CMV reactivation is lower in sibling versus UCB grafts, regardless of donor serostatus. Sibling donor Sero+, n = 63; 37% CMV reactivation; donor Sero−, n = 61; 33% CMV reactivation) versus UCB grafts (n = 270; 51% CMV reactivation). Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

Download ppt "Adaptive Natural Killer Cell and Killer Cell Immunoglobulin–Like Receptor–Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated."

Similar presentations

Cytomegalovirus Status and the Outcome of T Cell–Replete Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation  Frans M. Verduyn Lunel,

Cytomegalovirus Status and the Outcome of T Cell–Replete Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation  Frans M. Verduyn Lunel,
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen.

Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen.
Promising Progression-Free Survival for Patients Low and Intermediate Grade Lymphoid Malignancies after Nonmyeloablative Umbilical Cord Blood Transplantation 

Promising Progression-Free Survival for Patients Low and Intermediate Grade Lymphoid Malignancies after Nonmyeloablative Umbilical Cord Blood Transplantation 
Successful Remission Rates and Survival after Lymphodepleting Chemotherapy and Donor Lymphocyte Infusion for Relapsed Hematologic Malignancies Postallogeneic.

Successful Remission Rates and Survival after Lymphodepleting Chemotherapy and Donor Lymphocyte Infusion for Relapsed Hematologic Malignancies Postallogeneic.
Expansion of NKG2A−LIR1− Natural Killer Cells in HLA-Matched, Killer Cell Immunoglobulin-Like Receptors/HLA-Ligand Mismatched Patients following Hematopoietic.

Expansion of NKG2A−LIR1− Natural Killer Cells in HLA-Matched, Killer Cell Immunoglobulin-Like Receptors/HLA-Ligand Mismatched Patients following Hematopoietic.
Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft- versus-Host Disease  David A. Knorr, Hongbo Wang, Mukta Aurora,

Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft- versus-Host Disease  David A. Knorr, Hongbo Wang, Mukta Aurora,
Reduced-Intensity Conditioning Followed by Related Allografts in Hematologic Malignancies: Long-Term Outcomes Most Successful in Indolent and Aggressive.

Reduced-Intensity Conditioning Followed by Related Allografts in Hematologic Malignancies: Long-Term Outcomes Most Successful in Indolent and Aggressive.
Vaccination of Children following Allogeneic Stem Cell Transplantation

Vaccination of Children following Allogeneic Stem Cell Transplantation
Does the Hematopoietic Cell Transplantation Specific Comorbidity Index Predict Transplant Outcomes? A Validation Study in a Large Cohort of Umbilical.

Does the Hematopoietic Cell Transplantation Specific Comorbidity Index Predict Transplant Outcomes? A Validation Study in a Large Cohort of Umbilical.
Early Cytomegalovirus Reactivation Leaves a Specific and Dynamic Imprint on the Reconstituting T Cell Compartment Long-Term after Hematopoietic Stem Cell.

Early Cytomegalovirus Reactivation Leaves a Specific and Dynamic Imprint on the Reconstituting T Cell Compartment Long-Term after Hematopoietic Stem Cell.
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.

FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
Survival Differences between Adolescents/Young Adults and Children with B Precursor Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplantation 

Survival Differences between Adolescents/Young Adults and Children with B Precursor Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplantation 
Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation  Claudio G. Brunstein, Effie W. Petersdorf,

Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation  Claudio G. Brunstein, Effie W. Petersdorf,
Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation 

Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation 
Reconstitution of Natural Killer Cells in HLA-Matched HSCT after Reduced-Intensity Conditioning: Impact on Clinical Outcome  Caroline Pical-Izard, Roberto.

Reconstitution of Natural Killer Cells in HLA-Matched HSCT after Reduced-Intensity Conditioning: Impact on Clinical Outcome  Caroline Pical-Izard, Roberto.
Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation  Aazim K. Omer, Daniel J. Weisdorf, Aleksandr Lazaryan,

Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation  Aazim K. Omer, Daniel J. Weisdorf, Aleksandr Lazaryan,
KIR Donor Selection: Feasibility in Identifying better Donors

KIR Donor Selection: Feasibility in Identifying better Donors
Natural Killer Cell Differentiation from Hematopoietic Stem Cells: A Comparative Analysis of Heparin- and Stromal Cell–Supported Methods  Steven A. Dezell,

Natural Killer Cell Differentiation from Hematopoietic Stem Cells: A Comparative Analysis of Heparin- and Stromal Cell–Supported Methods  Steven A. Dezell,
Cytomegalovirus Immune Reconstitution Occurs in Recipients of Allogeneic Hematopoietic Cell Transplants Irrespective of Detectable Cytomegalovirus Infection 

Cytomegalovirus Immune Reconstitution Occurs in Recipients of Allogeneic Hematopoietic Cell Transplants Irrespective of Detectable Cytomegalovirus Infection 
Expansion of NKG2A−LIR1− Natural Killer Cells in HLA-Matched, Killer Cell Immunoglobulin-Like Receptors/HLA-Ligand Mismatched Patients following Hematopoietic.

Expansion of NKG2A−LIR1− Natural Killer Cells in HLA-Matched, Killer Cell Immunoglobulin-Like Receptors/HLA-Ligand Mismatched Patients following Hematopoietic.

Similar presentations

Ads by Google